Add BrightSurf on Google Email

Colonoscopy still most effective colorectal cancer screening method

The American Gastroenterological Association recommends colonoscopy as the preferred screening method for colorectal cancer due to its ability to detect and remove precancerous polyps. In-office fecal occult blood tests are not recommended as a standalone screening test, but can be used in conjunction with flexible sigmoidoscopy.

SourceAmerican Gastroenterological Association·JournalAnnals of Internal Medicine·DateJan 19, 2005

Colorectal cancer screening underutilized

Fewer than half of patients had received at least one screening test more than six months prior to diagnosis. Patients with a history of screening had earlier stage and presumably more treatable disease, highlighting the underuse of colorectal procedures in clinical practice.

SourceWiley·JournalCancer·DateJan 10, 2005

Study reveals genetic link to colon cancer

A recent study has revealed a genetic link to colon cancer, identifying the MutY human homologue (MYH) gene as a risk factor. The research found that children of MYH gene carriers have a higher risk of developing the disease, with a 1:2 ratio.

SourceUniversity of Toronto·JournalJNCI Journal of the National Cancer Institute·DateNov 2, 2004

Research news from the AGA

Increased use of virtual colonoscopy is expected to lead to a decrease in traditional colonoscopies due to improved detection rates. Virtual colonoscopy without bowel preparation has been found to be as effective as traditional colonoscopy in detecting colorectal polyps, increasing patient compliance and potential screening rates.

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateNov 1, 2004

Doctors can improve colorectal cancer screening rates

A UCLA study of 22,343 adults aged 50+ in California found that 54% had a recent CRC test, with disparities seen among Latinos, women, and those without insurance or continuity of care. Improving access to screening through policies and education programs can help address these gaps.

SourceWiley·JournalCancer·DateOct 25, 2004

Statement from the American Gastroenterological Association on colonoscopy surveillance study

The American Gastroenterological Association disputes the validity of a recent study suggesting that too many surveillance colonoscopies are being performed. The study, published in Annals of Internal Medicine, highlights the importance of determining the clinical significance of small polyps and notes the need for further research to ...

SourceAmerican Gastroenterological Association·JournalAnnals of Internal Medicine·DateAug 20, 2004

Drug that cuts off tumor's blood supply extends lives of colorectal cancer patients

Researchers found that combining Avastin with chemotherapy improves median survival, reduces risk of death and increases response rates in patients with advanced colorectal cancer. The study showed a nearly five-month improvement in patient survival, demonstrating the potential of targeting tumor blood supply as a viable treatment option.

SourceUniversity of California - Los Angeles·JournalNew England Journal of Medicine·DateJun 2, 2004

Different methods of adjuvant chemotherapy for colorectal cancer have similar outcomes

A randomized clinical trial found that regional and systemic adjuvant chemotherapy regimens had similar survival rates for colon cancer patients, with the combination regimen offering no added benefit. The study, published in the Journal of the National Cancer Institute, also showed lower adverse reaction rates for regional therapy.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 18, 2004

Other highlights in the April 7 JNCI

Two new studies found no association between aspirin use and mortality from pancreatic cancer, while elevated insulin production was linked to an increased risk of colorectal cancer. Hyperinsulinemia, a condition associated with type 2 diabetes, also appears to be linked to an increased risk of colorectal cancer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 6, 2004

Race may be a factor in treatment of rectal cancer patients

A recent study found racial disparities in the delivery of care to black and white rectal cancer patients. Black patients were diagnosed at a younger age and had more advanced disease, leading to differences in treatment outcomes. The study suggests that improved access to state-of-the-art surgical care for minority patients with recta...

SourceJAMA Network·JournalArchives of Surgery·DateFeb 9, 2004

Inflammation marker predicts colon cancer

A study published in The Journal of the American Medical Association found that people with higher CRP levels were more likely to develop colorectal cancers over an 11-year period. Median CRP levels were higher among those who developed colon cancer, and inflammation was linked to increased risk without being mediated by diabetes.

SourceJohns Hopkins Medicine·JournalJAMA·DateFeb 3, 2004

Other highlights in the February 4 issue of JNCI

Researchers discuss the need for additional research and standardization in partial-breast irradiation and accelerated partial-breast irradiation. A new study also finds that preoperative chemoradiation may benefit some patients with rectal cancer, while a diet high in glycemic load is linked to an increased risk of colorectal cancer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateFeb 3, 2004